Have you ever thought about joining a clinical trial? Now is a great time to start! ? Participants are needed for the AVALON clinical trial assessing the investigational drug VTP-1000 for the treatment of celiac disease. Compensation for time and travel may be available. To be eligible to participate, you must be 18–65 years old, have biopsy-confirmed celiac disease, have been on a gluten-free diet for 12+ months, and live in the US. Additional eligibility criteria apply. Learn more and see if you qualify: avalon.celiac.org #ClinicalTrial #ResearchOpportunity #MeedicalResearch
Celiac Disease Foundation
非盈利组织
Woodland Hills，CA 5,235 位关注者
We lead the fight to increase the rate of diagnosis, to improve treatments, and to find a cure.
关于我们
Celiac disease is one of the world’s most prevalent genetic autoimmune diseases, affecting an estimated 3 million Americans, 70-80% of whom are undiagnosed. Causing the body to attack its own small intestine, it can lead to many other devastating health conditions, including cancer. Unfortunately for the millions who suffer, celiac disease has largely been ignored by our federal government which provides little to no funding for research nor for public awareness of its serious consequences. Through strategic investments in research, education, and advocacy, the Celiac Disease Foundation seeks to remedy this by accelerating treatments and a cure. The Celiac Disease Foundation, established in 1990, is a leading global patient advocacy organization committed to accelerating diagnosis, treatments, and a cure for celiac disease. Our mission is to improve the health and well-being of the millions of individuals around the world affected by this genetic autoimmune disease through our strategic investments in research, advocacy, and education. Our iCureCeliac? patient registry and extensive patient recruitment services enable us to identify qualified patient candidates and speed their enrollment to advance critical disease research. Our unparalleled advocacy program has led the way to secure federal recognition and first-ever research funding from agencies including the U.S. National Institutes of Health and the Department of Defense. We adhere to the highest scientific and ethical standards as we work each day to promote understanding of celiac disease, empower our patient and provider community, and collaborate with partners and stakeholders to carry our mission forward.
- 网站
-
https://celiac.org
Celiac Disease Foundation的外部链接
- 所属行业
- 非盈利组织
- 规模
- 11-50 人
- 总部
- Woodland Hills，CA
- 类型
- 非营利机构
- 创立
- 1990
- 领域
- Celiac Disease、Gluten Sensitivity、Advocacy、Research、Support和Health
地点
-
主要
获取路线
5850 Canoga Avenue
4th Floor
US，CA，Woodland Hills，91367
Celiac Disease Foundation员工
-
Vanessa Weisbrod
Chief, Education and Community Engagement Officer at Celiac Disease Foundation
-
Marilyn Grunzweig Geller
Chief Executive Officer at Celiac Disease Foundation
-
Brett Spitale
Chief of Staff at the Celiac Disease Foundation
-
Yasith Weerasuriya
Member, Board Of Directors at Celiac Disease Foundation
动态
-
??Clinical trial now enrolling!?? AVALON is testing the investigational drug VTP-1000 for celiac disease. This investigational targeted immunotherapy is designed to prevent or reduce symptoms from accidental gluten exposure by promoting tolerance to gluten. You may be able to participate if you meet the following requirements: - 18–65 years old - Biopsy-confirmed celiac disease - Have been on a gluten-free diet for 12+ months - US resident Additional eligibility criteria apply, and compensation may be available for your time and travel. See if you qualify: avalon.celiac.org #MedicalResearch #HealthResearch #ResearchOpportunity
-
-
The SynCeD Study tests the safety and tolerability of the investigational drug KAN-101 in adults with celiac disease. KAN-101 acts by re-educating T cells, or tolerizing them, so they do not respond to gluten antigens. This is called immune tolerance. Requirements: - 18-70 years old - Biopsy-confirmed celiac disease - On a gluten-free diet for at least the last 12 months Compensation available. Learn more: Anokion.com/SynCeD See if you qualify: https://lnkd.in/gtdKfb-c
-
-
You work hard to stay gluten-free, but accidents are a part of life. What if you had a medication to help prevent or reduce your symptoms from cross-contact? That’s the potential of VTP-1000, an investigational drug being studied in the AVALON clinical trial.?Compensation for time and travel may be available. See if you qualify: avalon.celiac.org #CeliacDisease #GlutenFreeLife #HealthResearch
-
-
When you join a celiac disease clinical trial, your participation can directly impact how soon better treatments could become available. You can find out within minutes if you may qualify for any of the 3 trials currently enrolling participants in iQualifyCeliac. Click the link below for more information. https://lnkd.in/e3XRUxEF (or visit celiac.org/trials)
-
?? Celiac Cruise Giveaway! ?? We're so excited to give away a Celiac Cruise! Donate $25 or more between September 13th-20th and be entered to win a free Celiac Cruise for 2 to Bordeaux, France May 1-8, 2025. View link for more details! https://lnkd.in/eJ8JM7QH #CeliacCruise #CeliacAwareness #CruiseGiveaway #glutenfree #cruise #cruising #cruisingwithceliac #cruiselife
-
Happy birthday to Dr. Samuel Gee, the pioneer who first linked diet to celiac disease! ?? Thanks to his groundbreaking work, millions now thrive on a gluten-free diet. At the Celiac Disease Foundation, we continue his legacy by providing resources, support, and research to help people with celiac disease live healthier lives. #CeliacDisease #SamuelGee #GlutenFreeLife #CeliacAwareness #ThrivingWithCeliac #GlutenFree #AutoimmuneDisease #CeliacSupport #CeliacResearch #LivingGlutenFree #GutHealth #CeliacCommunity #glutenfree
-
The ACeD-it clinical trial is investigating a potential medicine for treating the symptoms of celiac disease after gluten exposure. Your participation could make a difference. Requirements: - 18-70 years old - Biopsy-confirmed celiac disease - On a gluten-free diet for at least the last 12 months Compensation is available for eligible participants. Learn more at Anokion.com/ACeD-it
-
-
Volunteers with celiac disease needed to participate in the SynCeD Study, a phase 2a clinical trial testing the investigational drug KAN-101. KAN-101 acts by re-educating T cells, or tolerizing them, so they do not respond to gluten antigens. This is called immune tolerance. Compensation available. Requirements: 18-70 years old Biopsy-confirmed celiac disease On a gluten-free diet for at least the last 12 months Learn more: Anokion.com/SynCeD See if you qualify: https://lnkd.in/gtdKfb-c
-
-
The ACeD-it Study is testing the safety and tolerability of the investigational drug KAN-101 in adults with celiac disease. KAN-101 acts by re-educating T cells, or tolerizing them, so they do not respond to gluten antigens. This is called immune tolerance. Requirements: 18-70 years old Biopsy-confirmed celiac disease On a gluten-free diet for at least the last 12 months Compensation available. See if you qualify: https://lnkd.in/gsPEhQxC Learn more: Anokion.com/ACeD-it
-